IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October 1, 2022 Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic Nicole C. Griffith, PharmD; Brandon K. Hill, PharmD; Myla D. Goldman, MD; S. Ross Tingen, PharmD Target Audience: The target audience for this activity is physicians, physician assistants, …

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for nursing professionals, 1.25 contact hours (.1 CEUs) for pharmacists, or 1.25 AAPA Category 1 CME credits The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options …

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022 Activity Overview This Clinical Consultations™ is a video-based program in which two experts discuss the management of patients with multiple sclerosis (MS) and SARS-CoV-2 vaccinations. In this activity, the faculty focus on the effects of disease modifying therapies (DMTs) on vaccine practices, specifically the mRNA …

ECHO MS

Description ECHO MS implements the evidence-based hub and spoke ECHO model™ to create a dynamic learning community between MS expert hub teams and community based MS healthcare providers. The National MS Society operates three hub teams in three time zones: Eastern, Central and Pacific.  The hub teams facilitate 12 interactive video conference sessions over a …

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by   Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and …

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration Date: November 30, 2021 Intended Audience: Physicians and their teams providing care for patients with MS (PAs, NPs, nurses, pharmacists) Accompanying this activity are resources to provide evidence-based guidance on necessary laboratory evaluations needed before initiating or switching DMTs, as well as a guide for …

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …